RPC1063
Drug
Celgene Corporation
Total Payments
$2.7M
Transactions
183
Doctors
21
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $2.7M | 183 | 21 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.7M | 169 | 99.7% |
| Consulting Fee | $5,200 | 1 | 0.2% |
| Travel and Lodging | $2,343 | 6 | 0.1% |
| Food and Beverage | $893.87 | 7 | 0.0% |
Payments by Type
Research
$2.7M
169 transactions
General
$8,437
14 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RPC01-3101 | Celgene Corporation | $838,915 | 1 |
| RPC01-1908 | Celgene Corporation | $805,278 | 0 |
| RPC01-3102 | Celgene Corporation | $325,980 | 1 |
| RPC01-1904 | Celgene Corporation | $262,098 | 0 |
| RPC01-2201 | Celgene Corporation | $245,821 | 3 |
| RPC02-201 | Celgene Corporation | $226,125 | 7 |
| RPC01-1001 | Celgene Corporation | $8,996 | 1 |
| RPC01-201-PartA | Celgene Corporation | $7,103 | 4 |
| RPC01-1906 | Celgene Corporation | $5,094 | 0 |
| RPC01-301 | Celgene Corporation | $5,004 | 4 |
| RPC01-201 | Celgene Corporation | $3,336 | 4 |
| RPC01-201-PartA RPC01-301 | Celgene Corporation | $3,213 | 3 |
| RPC02-201 HEREOS study | Celgene Corporation | $2,502 | 6 |
| RPC01-202 | Celgene Corporation | $1,251 | 3 |
| RPC01-1901 | Celgene Corporation | $578.00 | 1 |
Top Doctors Receiving Payments for RPC1063
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | South Boston, MA | $2.7M | 131 |
| , M.D | Gastroenterology | West Haven, CT | $10,100 | 1 |
| , MD | Ophthalmology | Palm Harbor, FL | $5,200 | 1 |
| , MD | Neurology | Stanford, CA | $5,036 | 4 |
| , M.D | Neurology | San Francisco, CA | $5,036 | 4 |
| , MD | Neurology | Cleveland, OH | $5,036 | 4 |
| , M.D | Pediatric Pathology | Cincinnati, OH | $3,784 | 2 |
| , M.D., M.P.H | Gastroenterology | Chapel Hill, NC | $3,784 | 2 |
| Ikuo Hirano | — | Chicago, IL | $3,784 | 2 |
| Amit Bar-Or | Neurology | Philadelphia, PA | $3,548 | 3 |
| , M.D | Cardiovascular Disease | Charlottesville, VA | $3,500 | 2 |
| , M.D | Allergy & Immunology | Cincinnati, OH | $3,367 | 2 |
| , MD | Pediatric Gastroenterology | Peoria, IL | $3,367 | 2 |
| , MD | Internal Medicine | Iowa City, IA | $3,367 | 2 |
| , MD, PHD | Internal Medicine | San Francisco, CA | $3,111 | 2 |
| , MD | Neurology | Knoxville, TN | $3,030 | 1 |
| , M.D | Specialist | Los Angeles, CA | $1,693 | 6 |
| , M.D | Anesthesiology | Placerville, CA | $1,575 | 1 |
| , D.O | Gastroenterology | Largo, FL | $1,545 | 7 |
| , M.D | Gastroenterology | San Diego, CA | $834.00 | 2 |
| , MD | Gastroenterology | Chicago, IL | $417.00 | 1 |
| , MD | Gastroenterology | Atlanta, GA | $417.00 | 1 |
Ad
Manufacturing Companies
- Celgene Corporation $2.7M
Product Information
- Type Drug
- Total Payments $2.7M
- Total Doctors 21
- Transactions 183
About RPC1063
RPC1063 is a drug associated with $2.7M in payments to 21 healthcare providers, recorded across 183 transactions in the CMS Open Payments database. The primary manufacturer is Celgene Corporation.
Payment data is available from 2017 to 2017. In 2017, $2.7M was paid across 183 transactions to 21 doctors.
The most common payment nature for RPC1063 is "Unspecified" ($2.7M, 99.7% of total).
RPC1063 is associated with 15 research studies, including "RPC01-3101" ($838,915).